Self-management of insulin by inpatients with diabetes in acute care – a randomized controlled trial

Not Applicable

• Conditions: Insulin dependent diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12622000445774
• Lead Sponsor: Mackay Hospital and Health Service

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-21
• Last Update Posted: 19 April 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Patients who have been self-managing their insulin prior to admission discharge.

Exclusion Criteria

•People who will not be self-managing their insulin on discharge
•People who are confused and not orientated to time and place
•People who lack mental capacity and have inability to provide informed consent
•People admitted with Diabetic Ketoacidosis (DKA) or Hyperosmolar Hyperglycaemic State (HHS) requiring an insulin infusion
•People whose clinical condition deteriorates e.g. becomes confused, more unwell, or dependent on nursing cares
•Physical disabilities that prevents self-administration

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of time blood glucose is in range (between 4 mmol/L to 10 mmol/L) assessed using a continuous blood glucose monitor[Across the 14-day trial period];Number of hypoglycaemia events (blood glucose level of 3.9 mmol/L or below) assessed using a continuous blood glucose monitor[Across the 14-day trial period];Number of hyperglycaemic events (blood glucose level > 10.1 mmol/L) assessed using a continuous blood glucose monitor[Across the 14-day trial period]